Skip to content

Use of probiotics to help treat gingivitis

Use of probiotics as adjuvant in gingivitis treatment: randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2yd7sy5
Enrollment
Unknown
Registered
2025-01-23
Start date
2025-03-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gengivitis

Interventions

This is a double-blind, randomized controlled clinical trial. In the experimental group, 20 people, of both genders, with Gingivitis will receive conventional periodontal treatment (Oral Hygiene Instr
G07.203.300.456.500

Sponsors

Universidade Iguaçu
Lead Sponsor
Universidade Veiga de Almeida
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Healthy volunteers; non-smokers; of both genders; over 18 years of age; must present Gingivitis characterized by the presence of gingival bleeding in more than 10% of the sites evaluated

Exclusion criteria

Exclusion criteria: Cigarete smokers; history of previous periodontal treatment; antibiotics use within the past 6 months; pregnancy; presence of acute or necrotizing lesions; history of diabetes; rheumatic fever; neurological deficiencies; immunological diseases; use of medications that affect periodontal tissues such as phenytoin, cyclosporine, nifedipine and anti-inflammatories

Design outcomes

Primary

MeasureTime frame
Bleeding on probing in pre- and post-treatment measurements. Verified through clinical probing of the gingival sulcus with a millimeter probe in 4 sites per tooth, with the final score being the percentage of sites with bleeding. Data collected pre-treatment and 15, 30 and 45 days after the intervention. It is expected to find a difference in the percentage of sites with bleeding on probing in pre- and post-treatment measurements

Secondary

MeasureTime frame
Visible biofilm in pre- and post-treatment measurements; Verified through visual assessment as absent or present in 4 sites per tooth, with the final score being the percentage of tooth surfaces with biofilm; Data collected pre-treatment and 15, 30 and 45 days after the intervention. It is expected to find a difference in the percentage of sites with visible biofilm in pre- and post-treatment measurements;Microbial levels in pre- and post-treatment measurements. Assessment of biofilm collected from 3 teeth per patient using DGGE and RT-PCR techniques, considering the type and quantity of bacteria in the sites. Data collected pre-treatment and 15, 30 and 45 days after the intervention. It is expected to find a statistically significant reduction in microbial levels in pre- and post-treatment measurements;Self-perceived quality of life in pre- and post-treatment measures. Assessment of the 7 dimensions of the OHIP-14 questionnaire, validated in Portuguese. Data collected pre-treatment and 15, 30 and 45 days after the intervention. A statistically significant improvement in self-perceived quality of life is expected in pre- and post-treatment measures

Countries

Brazil

Contacts

Public ContactJosé Provenzano

Universidade Iguaçu

odontojcp@gmail.com+55 (21) 27654039

Outcome results

None listed

Source: REBEC (via WHO ICTRP)